Cargando…
Type I interferon–mediated monogenic autoinflammation: The type I interferonopathies, a conceptual overview
Type I interferon is a potent substance. As such, the induction, transmission, and resolution of the type I interferon–mediated immune response are tightly regulated. As defined, the type I interferonopathies represent discrete examples of a disturbance of the homeostatic control of this system caus...
Autores principales: | Rodero, Mathieu P., Crow, Yanick J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5110029/ https://www.ncbi.nlm.nih.gov/pubmed/27821552 http://dx.doi.org/10.1084/jem.20161596 |
Ejemplares similares
-
The type I interferonopathies: 10 years on
por: Crow, Yanick J., et al.
Publicado: (2021) -
Human RELA dominant-negative mutations underlie type I interferonopathy with autoinflammation and autoimmunity
por: Moriya, Kunihiko, et al.
Publicado: (2023) -
Type I Interferonopathies in Children: An Overview
por: d'Angelo, Debora M., et al.
Publicado: (2021) -
Type I interferon-mediated autoinflammation due to DNase II deficiency
por: Rodero, Mathieu P., et al.
Publicado: (2017) -
Type I Interferonopathies in Childhood
por: Haşlak, Fatih, et al.
Publicado: (2023)